Recent studies demonstrate the expression of PROK1 in digestive tract cancer (gastric, small intestine, etc.), as well as in neuroblastoma, thyroid cancer, and pancreatic duct cancer [14–19]. Here, PROK1 is linked to pancreatic ductal adenocarcinoma.